GlassScriptPhysician profile
Daniel J Krause
NPI 1457768327
$3,578.69
in general payments reported to CMS, 2019-2025
18 companies · $330 in 2025
The $330 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15.51 · 2020: $125 · 2021: $110 · 2022: $358 · 2023: $2,154 · 2024: $485 · 2025: $330.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,751 · Travel and Lodging: $1,119 · Consulting Fee: $99.39.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,750.62 |
| Travel and Lodging | $1,119.16 |
| Consulting Fee | $99.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heartflow, INC. | $1,849.94 | 2023-2025 | Ffrct |
| Astrazeneca Pharmaceuticals LP | $261.95 | 2020-2025 | Farxiga |
| Inari Medical, INC. | $217.15 | 2023-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Amgen INC. | $208.79 | 2023-2025 | Repatha, Repatha |
| Janssen Pharmaceuticals, INC | $185.26 | 2019-2023 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $142.64 | 2022-2023 | Jardiance |
| Siemens Medical Solutions USA, INC. | $135.82 | 2024-2025 | Biograph Vision 600 (8 Ring/64 Ct) |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $114.37 | 2021-2025 | Lifevest |
| Novartis Pharmaceuticals Corporation | $113.44 | 2023-2025 | |
| Penumbra, INC. | $104.03 | 2024 | Indigo System |
| Abbott Laboratories | $93.13 | 2022 | |
| Pfizer INC. | $35.98 | 2023 | |
| Daiichi Sankyo INC. | $28.65 | 2025 | Injectafer |
| Novo Nordisk INC | $24.10 | 2023 | Ozempic |
| Lexicon Pharmaceuticals, INC. | $20.71 | 2023 | Inpefa |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $14.81 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $14.57 | 2023 | Camzyos |
| Merck Sharp & Dohme LLC | $13.35 | 2023 | Verquvo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Krause listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.